Allegiant Travel CO
ALGT Nasdaq Air Transportation, Scheduled Financials FY2016βFY2025
What Allegiant Travel CO does
No business description yet.
- Legal name
- Allegiant Travel CO
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001362468-26-000008
0001362468
Revenue and margins
Allegiant Travel CO had $2.6B of revenue in fiscal 2025, up 3.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $75.1M in fiscal 2025, 2.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Allegiant Travel CO returned $13.6M to shareholders in fiscal 2025, 18% of free cash flow. The diluted share count rose 1.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Allegiant Travel CO can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.2B | $955M | $815M | $781M | $806M |
| Debt incl. finance leases | $2.1B | $2.6B | $2.7B | $2.5B | $2.2B |
| Net debt / EBITDA | 2.0x | 5.7x | 4.3x | 93.9x | 4.9x |
| Debt / equity | 1.4x | 1.7x | 1.7x | 1.9x | 1.7x |
| Interest coverage | 3.8x | 0.8x | 1.4x | β1.5x | 0.2x |
| Current ratio | 2.0x | 1.5x | 0.8x | 0.8x | 1.0x |
| Quick ratio | 2.0x | 1.5x | 0.8x | 0.8x | 1.0x |
| Total assets | $4.0B | $4.5B | $4.9B | $4.4B | $4.2B |
| Total liabilities | $2.8B | $3.3B | $3.5B | $3.3B | $3.2B |
| Shareholders' equity | $1.2B | $1.2B | $1.3B | $1.1B | $1.1B |
| Net debt (β = net cash) | $878M | $1.6B | $1.9B | $1.7B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 5 / 8 | 5 / 8 | 4 / 8 | 7 / 8 | 4 / 8 | 6 / 8 | 4 / 8 | 6 / 8 |
| Accruals ratio | β7.6% | β10.0% | β8.3% | β7.6% | β13.4% | β10.7% | β7.1% | β6.5% | β12.5% | β10.1% |
| Altman Z'' | 3.50 | 2.42 | 2.34 | 2.45 | 1.24 | 2.97 | 1.96 | 1.28 | 0.29 | 1.07 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.4B | $1.5B | $1.7B | $1.8B | $990M | $1.7B | $2.3B | $2.5B | $2.5B | $2.6B |
| Net interest income | β | β | β | $59.8M | $50.9M | β$1.8M | β$16.5M | β$46.6M | β$44.0M | β$41.7M |
| Operating income | $373M | $231M | $243M | $364M | β$281M | $263M | $91.6M | $221M | β$240M | $37.2M |
| Interest expense | $28.8M | $42.2M | $56.1M | $76.8M | $61.7M | $68.5M | $116M | $153M | $156M | $150M |
| Pretax income | $348M | $199M | $199M | $301M | β$361M | $197M | $5.0M | $159M | β$308M | β$54.9M |
| Income tax | $127M | $0.9M | $37.5M | $69.1M | β$177M | $44.8M | $2.5M | $41.5M | β$68.2M | β$10.2M |
| Net income | $221M | $198M | $162M | $232M | β$184M | $152M | $2.5M | $118M | β$240M | β$44.7M |
| Diluted EPS | $13.29 | $12.13 | $10.00 | $14.26 | β$11.53 | $8.68 | $0.14 | $6.29 | β$13.49 | β$2.48 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $348M | $391M | $357M | $442M | $235M | $538M | $303M | $423M | $338M | $390M |
| Capital expenditure | $200M | $580M | $335M | $507M | $281M | $244M | $435M | $528M | $300M | $315M |
| Free cash flow | $148M | β$190M | $21.8M | β$64.6M | β$46.5M | $295M | β$132M | β$105M | $38.3M | $75.1M |
| Depreciation and amortization | $105M | $122M | $129M | $156M | $176M | $181M | $198M | $223M | $258M | $249M |
| Stock-based compensation | $9.4M | $13.9M | $15.1M | $18.2M | $19.3M | $16.1M | $15.2M | $29.7M | $22.6M | $10.9M |
| Share buybacks | $66.4M | $90.5M | $3.7M | $18.6M | $33.8M | $0.0M | $29.9M | $30.1M | $6.0M | $13.6M |
| Dividends paid | $67.5M | $45.7M | $45.2M | $45.6M | $11.4M | $0.0M | $0.0M | $22.1M | $21.9M | $0.0M |
| Dividends and buybacks | $134M | $136M | $48.9M | $64.1M | $45.1M | $0.0M | $29.9M | $52.2M | $28.0M | $13.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $64.7M | $59.4M | $396M | $458M | $685M | $1.2B | $955M | $815M | $781M | $806M |
| Total debt | $808M | $1.2B | $1.3B | $1.4B | $1.7B | $1.7B | $2.1B | $2.3B | $2.1B | $1.8B |
| Finance lease liabilities | β | β | β | $116M | $127M | $318M | $494M | $455M | $430M | $403M |
| Current assets | $422M | $541M | $495M | $562M | $944M | $1.3B | $1.3B | $1.0B | $992M | $968M |
| Current liabilities | $393M | $544M | $514M | $613M | $689M | $663M | $870M | $1.2B | $1.3B | $1.0B |
| Property and equipment, net | $1.1B | $1.5B | $1.8B | $2.2B | $2.1B | $2.3B | $2.8B | $3.4B | $3.1B | $2.9B |
| Total assets | $1.7B | $2.2B | $2.5B | $3.0B | $3.3B | $4.0B | $4.5B | $4.9B | $4.4B | $4.2B |
| Total liabilities | $1.2B | $1.6B | $1.8B | $2.1B | $2.6B | $2.8B | $3.3B | $3.5B | $3.3B | $3.2B |
| Shareholders' equity | $474M | $553M | $690M | $884M | $699M | $1.2B | $1.2B | $1.3B | $1.1B | $1.1B |
| Margins | ||||||||||
| Operating margin | 27.0% | 15.3% | 14.6% | 19.8% | β28.4% | 15.4% | 4.0% | 8.8% | β9.6% | 1.4% |
| EBITDA margin | 34.6% | 23.3% | 22.4% | 28.2% | β10.6% | 26.0% | 12.6% | 17.7% | 0.7% | 11.0% |
| Net margin | 16.0% | 13.1% | 9.7% | 12.6% | β18.6% | 8.9% | 0.1% | 4.7% | β9.6% | β1.7% |
| FCF margin | 10.8% | β12.5% | 1.3% | β3.5% | β4.7% | 17.2% | β5.7% | β4.2% | 1.5% | 2.9% |
| Net interest share of revenue | β | β | β | 3.2% | 5.1% | β0.1% | β0.7% | β1.9% | β1.8% | β1.6% |
| Returns | ||||||||||
| Return on capital | 19.9% | 13.8% | 12.6% | 15.2% | β13.3% | 11.4% | 2.5% | 5.9% | β8.0% | 1.4% |
| Return on capital employed | 29.1% | 14.1% | 12.3% | 15.2% | β10.9% | 7.9% | 2.5% | 6.0% | β7.6% | 1.2% |
| Return on equity | 46.6% | 38.6% | 26.0% | 29.5% | β23.3% | 15.8% | 0.2% | 9.2% | β19.9% | β4.2% |
| Return on assets | 13.2% | 10.3% | 6.9% | 8.4% | β5.9% | 4.2% | 0.1% | 2.5% | β5.2% | β1.0% |
| Return on tangible equity | 46.6% | 35.8% | 23.4% | 26.3% | β26.3% | 12.4% | 0.2% | 8.9% | β22.1% | β4.2% |
| Growth | ||||||||||
| Revenue growth | β | 9.6% | 10.3% | 10.4% | β46.2% | 72.5% | 34.8% | 9.0% | 0.1% | 3.7% |
| Net income growth | β | β10.3% | β18.3% | 43.5% | β179.3% | β | β98.4% | 4,617.0% | β304.3% | β |
| EPS growth | β | β8.7% | β17.6% | 42.6% | β180.9% | β | β98.4% | 4,392.9% | β314.5% | β |
| FCF growth | β | β227.7% | β | β396.0% | β | β | β144.7% | β | β | 96.1% |
| Share count change | β | β2.4% | β0.8% | 0.5% | β0.3% | 7.7% | 4.7% | β0.1% | β0.9% | 1.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.6x | 3.1x | 2.3x | 2.1x | β | 2.0x | 5.7x | 4.3x | 93.9x | 4.9x |
| Debt / equity | 1.7x | 2.1x | 1.8x | 1.6x | 2.4x | 1.4x | 1.7x | 1.7x | 1.9x | 1.7x |
| Interest coverage | 12.9x | 5.5x | 4.3x | 4.7x | β4.6x | 3.8x | 0.8x | 1.4x | β1.5x | 0.2x |
| Current ratio | 1.1x | 1.0x | 1.0x | 0.9x | 1.4x | 2.0x | 1.5x | 0.8x | 0.8x | 1.0x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 0.9x | 1.4x | 2.0x | 1.5x | 0.8x | 0.8x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 14.5% | 38.4% | 20.1% | 27.5% | 28.4% | 14.3% | 18.9% | 21.0% | 11.9% | 12.1% |
| Stock comp / revenue | 0.7% | 0.9% | 0.9% | 1.0% | 1.9% | 0.9% | 0.7% | 1.2% | 0.9% | 0.4% |
| Payouts / FCF | 90.2% | β | 223.9% | β | β | 0.0% | β | β | 73.0% | 18.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 5.0 | 5.0 | 4.0 | 7.0 | 4.0 | 6.0 | 4.0 | 6.0 |
| Altman Z'' | 3.5 | 2.4 | 2.3 | 2.5 | 1.2 | 3.0 | 2.0 | 1.3 | 0.3 | 1.1 |
| Accruals ratio | β7.6% | β10.0% | β8.3% | β7.6% | β13.4% | β10.7% | β7.1% | β6.5% | β12.5% | β10.1% |
Source: SEC EDGAR XBRL filings (CIK 0001362468). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.